News

NEWS CENTER
Your present position:
Home >
Laws & Regulations

NMPA Issued the Announcement on Revising the Package Inserts of Cefoperazone-Containing Drugs


To further protect the safety of public medication, NMPA released on March 7, 2019 the Announcement on Revising the Package Inserts of CefoperazoneContaining Drugs, with decisions made to revise the Entries of [Adverse reactions], [Contraindications], [Drug interactions] of the package inserts for cefoperazonec o n t a i n i n g d r u g s ( e n c o m p a s s i n g cefoperazone sodium for injection, cefoperazone sodium and sulbactam sodium for injection (1:1) and (2:1), cefoperazone sodium and tazobactam sodium for injection (4:1), and (8:1) ) .

 (March 7, 2019)